Our Clinical Studies

Rotigotine Transdermal Patch

Clinical studies are planned in 2021 to demonstrate the efficient transdermal delivery of a well-established Parkinson's disease medication.

CBD Oral/Sublingual Strip

Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of CBD for treatment-resistant Epilepsy.

THC Oral/Sublingual Strip

Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of THC for anorexia and nausea.

CBD:THC Oral/Sublingual Strip

Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of a combination of CBD and THC for Multiple Sclerosis-associated spasticity.

Parkinsons Transdermal Patch

Striving to improve patient outcomes for neurological disorders through innovative drug delivery methods

Our low-cost, non-invasive drug delivery methods have the potential to change the way patients can access the treatment they need for better quality of life.

Rapid Delivery and Production

We’re working with world-class life science industry and academic leaders

Scientist looking in magnifying glass XPhyto

Be in the know. Get our press releases and latest news first.

Hear about our latest research, products, exclusive partnerships & more.

Unsubscribe anytime. View our Privacy Policy for additional information.